Author: United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology Publisher: ISBN: Category : Business & Economics Languages : en Pages : 222
Book Description
Distributed to some depository libraries in microfiche.
Author: Ben Goldacre Publisher: Macmillan ISBN: 0865478066 Category : Business & Economics Languages : en Pages : 479
Book Description
Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Author: John Braithwaite Publisher: Routledge ISBN: 1135072906 Category : Social Science Languages : en Pages : 451
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Author: Quinn Grundy Publisher: Johns Hopkins University Press ISBN: 1421426757 Category : Medical Languages : en Pages : 179
Book Description
How sales representatives from Big Pharma and other healthcare companies circumvent public and regulatory scrutiny by forging relationships with nurses. Awarded second place in the 2019 AJN Book of the Year Award in the Professional Issues Category by the American Journal of Nursing It was once common for pharmaceutical companies and medical device makers to treat doctors to lavish vacations or give them new cars; companies would do virtually anything to buy influence so that their medications or devices would be used in a doctor’s office or hospital. But with growing public scrutiny of kickbacks to doctors, the huge giveaways have disappeared. In Infiltrating Healthcare, Quinn Grundy shows that sales representatives are working instead behind the scenes. It is to nurses that these companies now market. Nurses, Grundy argues, are the perfect target for sales reps: their work is largely invisible and frequently undervalued, yet they wield a great deal of influence over treatment and purchasing decisions. Furthermore, there are no legal restrictions on marketing to most nurses. Grundy describes how, under the guise of education or product support, and through gifts and free samples, sales representatives influence nurses in the course of day-to-day clinical practice. Grundy argues that the very presence of sales reps in operating rooms, purchasing committee meetings, and patient care units blurs the boundaries between patient care and medical sales. Helpfully, she also describes ways that nurses can be aware of (and resistant to) their influence. Infiltrating Healthcare is a call to action to protect the clinical spaces where we are at our most vulnerable—and the decisions that take place there—from the pursuit of profit at any cost. This is a timely book that shines a light on a practice that often goes unseen, and which has tangible implications for healthcare policy and practice.
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities Publisher: ISBN: Category : Competition, Unfair Languages : en Pages : 2188
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly Publisher: ISBN: Category : Pharmaceutical industry Languages : en Pages : 712
Author: United States. Congress. House. Select Committee on Narcotics Abuse and Control Publisher: ISBN: Category : Drug abuse Languages : en Pages : 140
Author: Ray Moynihan Publisher: Greystone Books ISBN: 1926706684 Category : Health & Fitness Languages : en Pages : 171
Book Description
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Author: United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Author: Ben Goldacre
Author: John Braithwaite
Author: Quinn Grundy
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Author: United States. Congress. House. Select Committee on Narcotics Abuse and Control
Author: Ray Moynihan
Author: 
Author: